JILLIAN SAVAGE: Open Payments
NPI 1275257081 · ARLINGTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 15 payments from 8 companies in 2025. Trend: 2023 $1,093 · 2024 $671 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $67 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
| UCB, Inc. | 2 | $48 |
| GENZYME CORPORATION | 3 | $43 |
| LEO Pharma Inc. | 1 | $23 |
| Organon LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: ILUMYA, Bimzelx, DUPIXENT, SKYRIZI, RINVOQ, ANZUPGO, TALTZ, LIBTAYO.
Industry payments across WA — which companies pay providers there.
